Janssen’s HIV treatment, ‘Presecobics’ applied by health insurance from March

Janssen Korea(CEO Ok-yeon Kim) announced ‘Presecobics(generic name: darunavir 800mg, cobicistat 150mg),’ a complex human immunodeficiency virus(HIV) treatment, will be applied by the National Health Insurance from the 1^st of March as a combination therapy of adult HIV patients under the Ministry of Health and Welfare’s official notification.

Presecobics has once acquired approval as a rare dis...